Regentatlantic Capital LLC Amgen Inc Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Regentatlantic Capital LLC holds 55,645 shares of AMGN stock, worth $14.7 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

55,645

Previous 57,289 2.87%

Holding current value

$14.7 Million

Previous $13.9 Million 10.02%

% of portfolio

0.38%

Previous 0.46%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $369,012 - $416,178	-1,644 Reduced 2.87%	55,645 $12.5 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $303,845 - $338,126	1,317 Added 2.35%	57,289 $13.9 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $183,528 - $203,031	837 Added 1.52%	55,972 $13.5 Million
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $168,252 - $192,549	-846 Reduced 1.51%	55,135 $12.4 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $476,546 - $558,331	-2,245 Reduced 3.86%	55,981 $11.9 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $636,271 - $705,897	2,724 Added 4.91%	58,226 $14.2 Million
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $429,395 - $500,391	1,935 Added 3.61%	55,502 $13.8 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $44,357 - $52,822	205 Added 0.38%	53,567 $12.3 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $65,232 - $72,544	-278 Reduced 0.52%	53,362 $13.6 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $934,652 - $1.15 Million	4,725 Added 9.66%	53,640 $12.7 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $301,789 - $400,255	-1,656 Reduced 3.27%	48,915 $9.92 Million
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $347,389 - $446,515	-1,836 Reduced 3.5%	50,571 $12.2 Million
Q3 2019 Oct 22, 2019	SELL	$174.11 - $208.62 $368,416 - $441,439	-2,116 Reduced 3.88%	52,407 $10.1 Million
Q2 2019 Jul 23, 2019	SELL	$166.7 - $195.41 $209,208 - $245,239	-1,255 Reduced 2.25%	54,523 $10 Million
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $137,642 - $155,152	-761 Reduced 1.35%	55,778 $10.6 Million
Q4 2018 Jan 30, 2019	SELL	$178.4 - $208.25 $452,422 - $528,122	-2,536 Reduced 4.29%	56,539 $11 Million
Q3 2018 Oct 30, 2018	SELL	$185.29 - $208.89 $1.83 Million - $2.06 Million	-9,864 Reduced 14.31%	59,075 $12.2 Million
Q2 2018 Jul 31, 2018	SELL	$166.05 - $186.51 $1.14 Million - $1.28 Million	-6,877 Reduced 9.07%	68,939 $12.7 Million
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $200,096 - $233,838	-1,181 Reduced 1.53%	75,816 $12.9 Million
Q4 2017 Jan 23, 2018	BUY	$168.79 - $188.59 $611,019 - $682,695	3,620 Added 4.93%	76,997 $13.4 Million
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $12.3 Million - $14 Million	73,377	73,377 $13.7 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Amgen Inc Transaction History